Lv1
86 积分 2024-06-10 加入
Safety Signals of GLP ‐1 Receptor Agonists: A Multi‐Method Pharmacovigilance Analysis of FAERS (2018–2025) With Sensitivity‐Stratified Prioritisation, Notoriety‐Bias Assessment, and Cross‐Database Validation
1个月前
已完结
Safety Profile of Tirzepatide in Real‐World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database
1个月前
已完结
Drug‐Associated Ketoacidosis: A Comprehensive Disproportionality Analysis Based on the FAERS Database
1个月前
已完结
The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine
1个月前
已完结
Signal mining for non-bleeding adverse event in novel oral anticoagulants: a pharmacovigilance study based on FAERS database
1个月前
已完结
Musculoskeletal adverse events with incretin-based diabetes drugs: a FAERS pharmacovigilance study
1个月前
已完结
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database
1个月前
已完结
Mining safety signals of PD-1/PD-L1 inhibitor-related adrenal insufficiency: a study based on the FAERS database
2个月前
已完结
Amputation and gangrene associated with SGLT2 inhibitors: pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
2个月前
已完结
Multi-database pharmacovigilance assessment of GLP-1 receptor agonist-related ophthalmic risks using advanced signal detection in FAERS and vigibase
2个月前
已完结
皖公网安备34019202002308
